Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.
Kalogris C, Garulli C, Pietrella L, Gambini V, Pucciarelli S, Lucci C, Tilio M, Zabaleta ME, Bartolacci C, Andreani C, Giangrossi M, Iezzi M, Belletti B, Marchini C, Amici A.
Kalogris C, et al. Among authors: pucciarelli s.
Biochem Pharmacol. 2014 Aug 1;90(3):226-34. doi: 10.1016/j.bcp.2014.05.014. Epub 2014 May 27.
Biochem Pharmacol. 2014.
PMID: 24875448